TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmapress Oy
Closing information (x1000 EUR)
Closing information | 2017/12 | 2016/12 | 2015/12 |
Turnover |
1,100
|
1,223
|
1,379 |
Financial expenses | 0 | ||
Earnings before taxes |
68
|
52
|
69 |
Total assets |
651
|
637
|
641 |
Current assets |
369
|
515
|
496 |
Current liabilities |
123
|
113
|
107 |
Equity capital |
527
|
524
|
533 |
- share capital |
30
![]() |
30
![]() |
30 |
Financial ratios
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Solvency |
81.0%
|
82.3%
|
83.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
6.2%
|
4.3%
|
5.0% |
Return on assets (ROA) | 10.8% | ||
Current ratio |
300%
|
455.8%
|
463.6% |
Return on equity (ROE) |
12.9%
|
9.9%
|
12.9% |
Change turnover |
-123
|
-156
|
-107 |
Change turnover % |
-10%
|
-11%
|
-7% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.